Samuel Hellman

An evidence-based analysis of the management of localized prostate cancer.

Transcriptional control of viral gene therapy by cisplatin.

Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy.

Sentinel lymph node versus axillary lymph node dissection for early-stage breast carcinoma: a comparison using a utility-adjusted number needed to treat analysis.

Consensus statement: Expedition Inspiration fund for breast cancer research meeting 2002.

Receiver operating characteristic analysis: a general tool for DNA array data filtration and performance estimation.

Early prostate cancer: clinical decision-making.

Expedition Inspiration Fund for Breast Cancer Research Meeting 2003.

Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma: a complication-adjusted number-needed-to-treat analysis.

Letrozole in breast cancer.

The natural history of breast carcinoma in the elderly: implications for screening and treatment.

Excision margins in high-risk malignant melanoma.

Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity.

Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.

Hormone therapy and radiotherapy for early prostate cancer: a utility-adjusted number needed to treat (NNT) analysis.

Debunking dogma and developing theses.

Premise, promise, paradigm and prophesy.

Importance of local control in an era of systemic therapy.

Evolving paradigms and perceptions of cancer.

Irwin Freedberg and the changing times of academic medicine.

Unintended consequences.

Early prostate cancer: hedonic prices model of provider-patient interactions and decisions.

Stem-cell biology and cancer therapy: the more things change...

An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease.

Advances in radiotherapy and implications for the next century: a historical perspective.

On first looking into Kutcher's "Contested Medicine": ethical tensions in clinical research.

Oligometastases revisited.

Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.

MicroRNA expression characterizes oligometastasis(es).

Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs.

Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy.

Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs.

Learning while caring: medicine's epistemology.

Clinical cancer research: the past, present and the future.

14q32-encoded microRNAs mediate an oligometastatic phenotype.

Imaging of tumor clones with differential liver colonization.

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.